Equity Analysis /
United States of America

US : Landos Biopharma, Inc. - LABP | 4Q21 Update: Full Rebuild Underway

    Contributors
    Timur Ivannikov
    Ryan Deschner
    CGS-CIMB
    26 March 2022
    Published by